Skip to main content

CHOP Omics Initiative News

Omics helps us get closer to more precise treatments for every patient. Learn what omics means and how we’re revolutionizing the future of pediatric medicine. 

FDA Approves Two Gene Therapies for Sickle Cell Disease

Dec 8, 2023

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Vaccine News & Notes — December 2023

Dec 7, 2023

Find out about Mrs. Carter’s impact on vaccines in the U.S. Check out a study on influenza disease and vaccine in kids. And find out about the Polio Network, a national and international resource for individuals and families affected by polio.

Feature Article: RRPF – “While We Breathe, We Hope”

Dec 7, 2023

Recurrent respiratory papillomatosis (RRP) is a disease characterized by the growth of noncancerous tumors around the vocal cords caused by HPV infection. Find out more about RRP and the work of the Recurrent Respiratory Papillomatosis Foundation.

Why I Give: Karyn Wire

Nov 27, 2023

In 2016, our 8-year-old son Justin was airlifted to CHOP for emergency brain surgery. It hit us out of nowhere. When his sister and brother visited, Child Life came in with things like Legos and Play-Doh to distract them from his scary head wrap and get them to just play together. It took the fear out of the room.

CHOP Receives 2023 Digital Health Most Wired Recognition

Dec 4, 2023

The College of Healthcare Information Management Executives (CHIME) has released their Digital Health Most Wired Survey results for the 2023 data collection period, and Children's Hospital of Philadelphia (CHOP) is excited to announce we have maintained our highest ranking to date: Acute Level 8 achievement for the Digital Health Most Wired range.

Jump back to top